Libourne, 12th November 2024 – Ceva Animal Health (Ceva), the leading French animal health company and the 5th largest global player, present in 110 countries officially launches its latest innovation: Ceva Genesys, for automatic and accurate broiler male and female separation at hatch to achieve better flock homogeneity.
With an increase in demand for poultry meat and a rising concern about environmental impact, the need to optimize the production process for a sustainable poultry meat supply is becoming more and more critical for poultry producers. As a leading poultry animal health company and specialist in hatchery technology, Ceva is well-positioned to support these goals.
Committed to actively supporting producers, Ceva has always been looking for innovation, especially at the hatchery, enabling an increase in poultry production performance.
“Since 2011, Ceva has worked side-by-side with the poultry industry to modernize hatchery processes. We have successfully equipped more than 150 hatcheries with the next generation of candling technology, Laser Life, or the in-ovo vaccination system, Egginject. Building on our success, we are now installing our latest state-of-the-art technology, Ceva Genesys, for gender sorting for broilers. We are pleased to offer our customers this innovation, which will bring value across their entire production chain,” said Sylvain Comte, Poultry Franchise Director at Ceva Animal Health.
Ceva Genesys allows for automatic broiler male and female sorting at hatch. By ensuring consistent gender sorting accuracy, poultry producers can optimize the rearing process to closely fit the birds’ needs, consequently improving flock performance.
Since Q3 2024, Ceva has engaged in and installed several commercial projects of Genesys across the world.
Ceva Genesys will be officially launched at the Eurotier (Hannover, Germany) and Ovum (Punta del Este, Uruguay) the week of the 12-15th of November.
— End —
About Ceva Animal Health
Ceva Animal Health (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers.
With more than 7,000 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: “Together, beyond animal health”.
2023 turnover: €1.6 billion